Hideo Saka
- Pulmonary and Respiratory Medicine top 0.2%
- Oncology top 0.5%
- Molecular Biology top 5%
- Surgery top 5%
- Cancer Research top 5%
- Co-authors
- Masahide OkiChiyoe KitagawaMasahiko AndoYoshihito KogureKaoru ShimokataYukio AndoYoshinori HasegawaToshiyuki Sawa
- Topics
- Lung Cancer Treatments and Mutations (91 papers)Lung Cancer Diagnosis and Treatment (84 papers)Tracheal and airway disorders (61 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hideo Saka
223 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Pulmonary and Respiratory Medicine 4.4k
- Oncology 3.1k
- Molecular Biology 1.3k
- Surgery 717
- Cancer Research 501
Countries citing papers authored by Hideo Saka
This map shows the geographic impact of Hideo Saka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideo Saka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideo Saka more than expected).
Fields of papers citing papers by Hideo Saka
This network shows the impact of papers produced by Hideo Saka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideo Saka. The network helps show where Hideo Saka may publish in the future.
Co-authorship network of co-authors of Hideo Saka
This figure shows the co-authorship network connecting the top 25 collaborators of Hideo Saka. A scholar is included among the top collaborators of Hideo Saka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideo Saka. Hideo Saka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 8 | |
| 6 | 23 | |
| 7 | 9 | |
| 8 | 0 | |
| 9 | 9 | |
| 10 | 40 | |
| 11 | 1 | |
| 12 | Safety/Tolerability of 1L Pembrolizumab+Chemotherapy in Japanese Patients with Metastatic Nonsquamous NSCLC: KEYNOTE-189 | 0 |
| 13 | 2 | |
| 14 | 15 | |
| 15 | 2 | |
| 16 | 8 | |
| 17 | 15 | |
| 18 | Phase II Study of Carboplatin and Pemetrexed in Advanced EGFR-wild-type Non-squamous Non-small Cell Lung Cancer: The Central Japan Lung Study Group Trial 0906. | 4 |
| 19 | 182 | |
| 20 | Is Bronchoscopy with a Thin Bronchoscope More Tolerable Than with a Standard Bronchoscope? : A Retrospective Analysis | 3 |
About Hideo Saka
Hideo Saka is a scholar working on Pulmonary and Respiratory Medicine, Anesthesiology and Pain Medicine and Oncology, having authored 238 papers that have together received 6.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (91 papers), Lung Cancer Diagnosis and Treatment (84 papers) and Tracheal and airway disorders (61 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.4k citations), Oncology (3.1k citations) and Otorhinolaryngology (164 citations). Hideo Saka has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masahide Oki, Chiyoe Kitagawa, Masahiko Ando, Yoshihito Kogure, Kaoru Shimokata, Yukio Ando, Masahide Oki, Yoshinori Hasegawa, Toshiyuki Sawa and Nobuyuki Yamamoto. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.